Vimian Group (OM:VIMIAN) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

VIMIAN Aktienübersicht

Vimian Group AB (publ) ist weltweit im Bereich der Tiergesundheit tätig.

VIMIAN fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	2/6
Financial Health	1/6
Dividends	0/6

Belohnungen

37.6% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 59.11% pro Jahr

In diesem Jahr profitabel geworden

Risikoanalyse

Zinszahlungen sind nicht ausreichend durch Erträge gedeckt

Die Aktionäre wurden im vergangenen Jahr verwässert

Große einmalige Posten, die sich auf die Finanzergebnisse auswirken

Vimian Group AB (publ) Wettbewerber

Xvivo Perfusion

OM:XVIVO

kr13.6b

Bactiguard Holding

OM:BACTI B

kr2.5b

OssDsign

OM:OSSD

kr940.5m

Arjo

OM:ARJO B

kr12.5b

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Vimian Group
Historical stock prices
Current Share Price	kr33.35
52 Week High	kr36.00
52 Week Low	kr20.08
Beta	1.52
1 Month Change	7.58%
3 Month Change	20.40%
1 Year Change	8.21%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-58.78%

Aktuelle Nachrichten und Updates

Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 18

Recent updates

Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 18

Vimian Group AB (publ) (STO:VIMIAN) Shares Could Be 40% Below Their Intrinsic Value Estimate

Apr 09

There's Been No Shortage Of Growth Recently For Vimian Group's (STO:VIMIAN) Returns On Capital

Nov 01

Vimian Group AB (publ)'s (STO:VIMIAN) Intrinsic Value Is Potentially 92% Above Its Share Price

Aug 27

When Should You Buy Vimian Group AB (publ) (STO:VIMIAN)?

Jul 19

Are Investors Undervaluing Vimian Group AB (publ) (STO:VIMIAN) By 27%?

May 19

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Apr 04

Calculating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)

Jan 06

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Dec 09

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 38% Discount?

Aug 25

We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)

Jun 18

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?

May 19

Does This Valuation Of Vimian Group AB (publ) (STO:VIMIAN) Imply Investors Are Overpaying?

Feb 07

Risks Still Elevated At These Prices As Vimian Group AB (publ) (STO:VIMIAN) Shares Dive 28%

Nov 30

Aktionärsrenditen

	VIMIAN	SE Medical Equipment	SE Markt
7D	1.4%	-0.3%	-1.3%
1Y	8.2%	-7.9%	13.4%

Rendite im Vergleich zur Industrie: VIMIAN übertraf die Branche Swedish Medical Equipment, die im vergangenen Jahr eine Rendite von -8.3 erzielte.

Rendite vs. Markt: VIMIAN hinter dem Markt Swedish zurück, der im vergangenen Jahr eine Rendite von 14.3 erzielte.

Preisvolatilität

Is VIMIAN's price volatile compared to industry and market?
VIMIAN volatility
VIMIAN Average Weekly Movement	6.6%
Medical Equipment Industry Average Movement	7.1%
Market Average Movement	5.9%
10% most volatile stocks in SE Market	12.9%
10% least volatile stocks in SE Market	3.5%

Stabiler Aktienkurs: VIMIAN hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: VIMIANDie wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2020	1,100	Patrik Eriksson	vimian.com

Die Vimian Group AB (publ) ist weltweit im Bereich der Tiergesundheit tätig. Das Unternehmen ist in den Segmenten Specialty Pharma, MedTech, Diagnostics und Veterinary Services tätig. Unter dem Markennamen Nextmune bietet das Unternehmen eigene Diagnostika, verschreibungspflichtige und nicht verschreibungspflichtige Behandlungen für die präventive Pflege und die Behandlung chronischer Erkrankungen von Haustieren an.

Vimian Group AB (publ)'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Vimian Group im Vergleich zum Marktanteil des Unternehmens?
VIMIAN grundlegende Statistiken
Marktanteil	kr17.42b
Gewinn(TTM)	kr90.01m
Umsatz(TTM)	kr3.80b

193.6x

Kurs-Gewinn-Verhältnis

4.6x

Kurs-Umsatz-Verhältnis

Ist VIMIAN zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
VIMIAN Gewinn- und Verlustrechnung (TTM)
Einnahmen	€334.95m
Kosten der Einnahmen	€103.16m
Bruttogewinn	€231.79m
Sonstige Ausgaben	€223.85m
Umsatz	€7.94m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

Aug 15, 2024

Gewinn per Aktie (EPS)	0.015
Bruttomarge	69.20%
Nettogewinnspanne	2.37%
Schulden/Eigenkapital-Verhältnis	57.4%

Wie hat sich VIMIAN auf lange Sicht entwickelt?

Historische Performance und Vergleiche

VIMIAN Aktienübersicht

Belohnungen

Risikoanalyse

Vimian Group AB (publ) Wettbewerber

OM:XVIVO

kr13.6b

OM:BACTI B

kr2.5b

OM:OSSD

kr940.5m

OM:ARJO B

kr12.5b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Vimian Group AB (publ) Elects Magnus Welander to Board as Chairman of the Board

New minor risk - Earnings quality

Independent Director recently bought kr386k worth of stock

Consensus EPS estimates fall by 24%

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Recent updates

Vimian Group AB (publ) Elects Magnus Welander to Board as Chairman of the Board

New minor risk - Earnings quality

Independent Director recently bought kr386k worth of stock

Consensus EPS estimates fall by 24%

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2023 earnings: EPS misses analyst expectations

Vimian Group AB (publ) (STO:VIMIAN) Shares Could Be 40% Below Their Intrinsic Value Estimate

Vimian Group AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 1.632566 billion.

Full year 2023 earnings released: EPS: €0.022 (vs €0.017 loss in FY 2022)

Vimian Group (STO:VIMIAN) Is Experiencing Growth In Returns On Capital

Little Excitement Around Vimian Group AB (publ)'s (STO:VIMIAN) Revenues

Vimian Group AB (publ) Announces CEO Changes

Why Vimian Group AB (publ) (STO:VIMIAN) Could Be Worth Watching

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

There's Been No Shortage Of Growth Recently For Vimian Group's (STO:VIMIAN) Returns On Capital

Fidelio Capital acquired a 12% stake in Vimian Group AB (publ) for approximately SEK 240 million.

Chairman of the board recently bought kr235m worth of stock

Vimian Group AB (publ) to Report Q3, 2024 Results on Oct 24, 2024

Vimian Group AB (publ)'s (STO:VIMIAN) Intrinsic Value Is Potentially 92% Above Its Share Price

New major risk - Financial position

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

When Should You Buy Vimian Group AB (publ) (STO:VIMIAN)?

Chief Executive Officer recently bought kr605k worth of stock

Vimian Group AB (publ) Announces Fredrik Ullman Step Down as CEO

Vimian Group AB (Publ) Elects Robert Belkic as New Board Member

Are Investors Undervaluing Vimian Group AB (publ) (STO:VIMIAN) By 27%?

Full year 2022 earnings released: €0.017 loss per share (vs €0.019 profit in FY 2021)

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Chief Executive Officer recently bought kr1.1m worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 23% undervalued after recent price drop

Calculating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)

Investor sentiment deteriorated over the past week

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Third quarter 2022 earnings released

Vimian Group AB (publ) to Report Q2, 2023 Results on Aug 17, 2023

High number of new and inexperienced directors

Vimian Group AB (publ), Annual General Meeting, Jun 01, 2023

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Vimian Appoints Carl-Johan Ehn as General Counsel and Member of the Vimian Group Management Team

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 38% Discount?

Second quarter 2022 earnings: Revenues exceed analyst expectations

Vimian Group AB (publ) (OM:VIMIAN) acquired Heiland Gmbh.

Vimian Group AB (publ) Appoints Carl-Johan Zetterberg Boudrie as CFO and Member of Management Team

We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)

Now 22% undervalued after recent price drop

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Vimian Group AB (publ) to Report Q2, 2022 Results on Aug 11, 2022

Less than half of directors are independent

Now 20% undervalued after recent price drop

Vimian Group AB (publ) (OM : VIMIAN) acquired VerticalVet, LLC.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 22% undervalued after recent price drop

Does This Valuation Of Vimian Group AB (publ) (STO:VIMIAN) Imply Investors Are Overpaying?

Vimian Group AB (publ) (OM:VIMIAN) signed an agreement to acquire Kahu Vet Group for €22.5 million.

Investor sentiment improved over the past week

Erträge & Einnahmen